Anzeige
Mehr »
Freitag, 18.09.2026 - Börsentäglich über 12.000 News
Heimlicher Börsenstar 2026?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
631 Leser
Artikel bewerten:
(2)

Biotalys' First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product

Ghent, Belgium, May 25, 2022 (GLOBE NEWSWIRE) -- Press release


Biotalys, an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announced that its biocontrol Evoca* won the World BioProtection Award 2022 for Best Biofungicide Product. The award was granted at the World BioProtection Summit taking place in Birmingham (UK) this week, based on the innovative character, scientific value and market potential of the product.

Evoca is the first protein-based biofungicide developed on Biotalys' AGROBODY Foundry platform. It helps control fungal diseases such as Botrytis and powdery mildew in fruits and vegetables. Once approved by regulatory authorities, Evoca will provide growers with a new rotation partner in integrated pest management (IPM) programs, reducing the dependency on chemical pesticides while protecting yields.

Patrice Sellès, CEO of Biotalys said: "We are honored to receive this global award for Evoca, the first biocontrol product developed on our unique technology platform. Demonstrating the strength of our technology and approach, this award recognizes the hard work of our colleagues and the scientific excellence of our teams to develop a new and effective tool for growers to protect their crops from fungal diseases." "This is a great encouragement for all stakeholders connected to our company as we prepare the market introduction of the product in select markets in the U.S. following regulatory approval expected later this year," commented Patrick McDonnell, Chief Business Officer at Biotalys.

Biotalys recently published the key findings of its latesttrials withEvoca, showing that the product consistently outperformed a leading chemical fungicide when applied at the flowering stage in a Botrytis control program in grapes. Validating the strength and efficacy of the product, the company's global field trial program with Evoca now encompasses more than 600 independentand company-driven field and greenhouse trialsacross multiple seasons, regions, climates, soil types, production types, pathogen pressure and crops.

Earlier in May 2022, Evoca'sactive ingredient received an entirely new resistance class by the FRAC- the Fungicide Resistance Action Committee. The new classification granted by this highly reputed international panel of renown technical experts, demonstrates to growers that the product will be a new tool that complements existing biological and conventional crop protection solutions to fight the fungal diseases Botrytis and powdery mildew. Evoca is on track to obtain approval by the U.S. Environmental Protection Agency, which includes biofungicides, biobactericides and bio-insecticides.

The World BioProtection Awards are granted by the World BioProtection Forum (WBF), a non-profit organisation that encourages collaboration between the biocontrol industry and academia in the AgriTech sector. The award ceremony this year took place in Birmingham (UK), where sector leaders and academics shed their light on the importance of biological crop protection. The ceremony was attended by Frédéric Grimault, Head of Business Development and Marketing EMEA& APACfor Biotalys, who received the award at the event on behalf of the company. The award was jointly granted to both Evoca and another biofungicide. More information can be found at https://www.worldbioprotectionforum.com/awbsa2022/.

Photo: Frédéric Grimault, Head Business Development and Marketing EMEA & APAC for Biotalys (center)

* Evoca: Pending Registration. This product is not currently registered for sale or use in the United States, the European Union,or elsewhere and is not being offered for sale.

About Biotalys

Biotalys is an Agricultural Technology.

For further information, please contact

Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com

ImportantNotice

This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. The Biotalys actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.

Attachments

  • Biotalys Press Release - Biotalys First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product (https://ml.globenewswire.com/Resource/Download/f0abd949-b71f-43e5-ba05-2c2aad87a90b)
  • Biotalys Persbericht - Biotalys' eerste biologische middel Evoca wint World BioProtection Award 2022 voor beste biofungicide (https://ml.globenewswire.com/Resource/Download/e18c0ed1-fe9a-455a-af51-235dfba3e0e8)

© 2022 GlobeNewswire (Europe)
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.